Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -167,747 | -122,690 | -52,853 | -259,622 | -213,555 |
| Depreciation Amortization | 89,874 | 74,032 | 27,806 | 225,912 | 198,816 |
| Income taxes - deferred | N/A | N/A | N/A | 11 | N/A |
| Accounts receivable | 15,777 | 10,661 | 10,160 | 14,359 | 25,789 |
| Accounts payable and accrued liabilities | -1,832 | 1,074 | -708 | 723 | -1,531 |
| Other Working Capital | 11,447 | 6,632 | 5,490 | -12,614 | -2,172 |
| Other Operating Activity | 17,676 | 10,636 | 715 | 38,696 | 14,756 |
| Operating Cash Flow | $-34,805 | $-19,655 | $-9,390 | $7,465 | $22,103 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,035 | -8,109 | -5,235 | -29,658 | -23,809 |
| Net Acquisitions | -18,990 | -18,990 | -18,628 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -1,500 | -1,000 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -300 | N/A |
| Other Investing Activity | 734 | 734 | 734 | 6,842 | 5,424 |
| Investing Cash Flow | $-29,291 | $-26,365 | $-23,129 | $-24,316 | $-19,385 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 953 | N/A |
| Debt Repayment | -4,650 | -3,090 | -1,543 | -235,026 | -4,533 |
| Other Financing Activity | -10,033 | -3,344 | -3,357 | -1,639 | 5,010 |
| Financing Cash Flow | $-14,683 | $-6,434 | $-4,900 | $-235,712 | $477 |
| Exchange Rate Effect | -46 | -38 | 73 | N/A | N/A |
| Beginning Cash Position | 322,399 | 322,399 | 322,399 | 574,962 | 574,962 |
| End Cash Position | 243,574 | 269,907 | 285,053 | 322,399 | 578,157 |
| Net Cash Flow | $-78,825 | $-52,492 | $-37,346 | $-252,563 | $3,195 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,805 | -19,655 | -9,390 | 7,465 | 22,103 |
| Capital Expenditure | -11,035 | -8,109 | -5,235 | -29,658 | -23,809 |
| Free Cash Flow | -45,840 | -27,764 | -14,625 | -22,193 | -1,706 |